cephalosporin c has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosaka, Y; Iwakawa, K; Kizu, J; Yamamoto, K | 1 |
| Ewing, RE; Gray, BK; MacDermott, JP; Somerville, JF | 1 |
1 trial(s) available for cephalosporin c and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Cephradine prophylaxis in transurethral procedures for carcinoma of the bladder.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cephalosporins; Cephradine; Clinical Trials as Topic; Cystoscopy; Humans; Middle Aged; Postoperative Complications; Premedication; Prospective Studies; Random Allocation; Urinary Bladder Neoplasms; Urinary Tract Infections | 1988 |
1 other study(ies) available for cephalosporin c and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
"Cephem-induced vancomycin resistance" observed in phenotypically methicillin-sensitive Staphylococcus aureus isolated from a patient treated with vancomycin and cephems.
Topics: Carcinoma, Transitional Cell; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillins; Phenotype; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Urinary Bladder Neoplasms; Vancomycin Resistance | 2000 |